NAD+: The Complete Research Guide

What is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It is one of the most fundamental molecules in biology — a small, diffusible carrier that shuttles electrons between reactions and acts as a required cofactor for hundreds of enzymes. In the research literature it sits at the intersection of energy metabolism, cellular signaling, and aging biology.

The molecule exists in two interconverting forms: an oxidized form, NAD+, and a reduced form, NADH. The balance between them — the NAD+/NADH couple — is one of the central readouts of a cell's metabolic state. When researchers refer simply to "NAD+," they often mean the whole NAD pool and the biology that depends on it. It is studied exclusively in laboratory research and is not a medicine.

How NAD+ works: redox metabolism and the NAD+/NADH couple

NAD+'s best-characterized role is as an electron carrier in redox (reduction–oxidation) reactions. In hundreds of metabolic steps, an enzyme strips electrons from one molecule and hands them to NAD+, converting it to NADH; elsewhere, NADH gives those electrons up and returns to NAD+. This continuous cycling is how cells move chemical energy from the food-derived molecules they break down to the machinery that captures it.

• Glycolysis — NAD+ accepts electrons as glucose is broken down, an early step in extracting energy from sugar.
• The citric acid (TCA) cycle — several steps reduce NAD+ to NADH inside the mitochondria.
• Fatty-acid oxidation — the breakdown of lipids for energy also feeds electrons into the NAD pool.
• The NAD+/NADH ratio — the balance of the two forms is widely used in research as an indicator of a cell's redox and metabolic state.

NAD+ and cellular energy: mitochondria and ATP

The electrons NAD+ collects do not stay on NADH for long. In the mitochondria, NADH delivers them to the electron transport chain — the series of protein complexes that ultimately produce ATP, the cell's primary energy currency. In this sense NAD+ is the loading dock and NADH the delivery vehicle for the raw material of cellular energy production.

Because so much of ATP synthesis depends on a steady supply of NAD+ to keep accepting electrons, the size and turnover of the cellular NAD pool is a recurring variable in bioenergetics and mitochondrial research. A cell that cannot regenerate NAD+ quickly enough is limited in how much energy it can extract, which is why the coenzyme is so often studied alongside mitochondrial function.

NAD+-dependent enzymes: sirtuins, PARPs, and CD38

Beyond carrying electrons, NAD+ is also consumed as a substrate by several families of enzymes. These enzymes cut NAD+ apart to do their work, which ties their activity directly to how much NAD+ is available. Three families draw the most research attention:

• Sirtuins (SIRT1–SIRT7) — a family of NAD+-dependent enzymes studied extensively in aging research for their association with gene regulation, mitochondrial biogenesis, and stress responses. Their activity depends on available NAD+, a major reason the coenzyme is linked to longevity science.
• PARPs (poly-ADP-ribose polymerases) — NAD+-consuming enzymes central to DNA-repair signaling. When DNA damage is detected, PARP activity rises and draws heavily on the NAD pool.
• CD38 — an NAD+-degrading enzyme studied for its role in immune signaling and as a major consumer of cellular NAD+; its activity is characterized in research as increasing with age.

Because sirtuins, PARPs, and CD38 all draw on the same finite NAD+ pool, researchers frequently study them together — the availability of NAD+ effectively couples energy metabolism, DNA-repair signaling, and aging biology to one another.

NAD+ and aging research

One of the most cited observations in the NAD+ literature is that cellular NAD+ levels are characterized as declining with age across many tissues and model systems. Because sirtuins and other repair- and metabolism-related enzymes depend on NAD+, this age-associated decline has made the coenzyme a central focus of longevity and aging research, cellular-energy research, and metabolic research.

This is the context in which NAD+ and its precursors are most often investigated — not as an "anti-aging" promise, but as a molecule whose availability is studied in relation to the biology of aging in controlled laboratory settings. The research question is typically how NAD pool size relates to the enzymes and pathways described above, work that remains firmly preclinical.

NAD+ vs. its precursors: NMN and NR

Cells do not only obtain NAD+ directly — they also build and recycle it from smaller precursor molecules through the salvage pathway. Two precursors dominate the research literature: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Both are studied as building blocks that feed NAD+ biosynthesis, and both are frequently compared with NAD+ itself.

The practical distinction researchers draw is one of position in the pathway: NAD+ is the functional coenzyme itself, while NMN vs NAD+ and NR-vs-NAD+ comparisons are really questions about supplying the pathway upstream versus studying its end-product directly. Peptora supplies research-grade NAD+ as a lyophilized powder, each lot backed by its own certificate of analysis.

What the research explores

In laboratory settings, NAD+ is most often studied across a handful of interconnected areas:

• Cellular energy and bioenergetics — how NAD pool size and the NAD+/NADH ratio relate to mitochondrial function and ATP production.
• Aging and longevity research — the age-associated decline of NAD+ and its relationship to sirtuin activity.
• DNA-repair signaling — PARP-mediated responses that draw on the NAD+ pool.
• Metabolic research — glucose and lipid handling in models where NAD+ availability is a variable.
• Redox biology — NAD+ as a core electron carrier across the major metabolic pathways.

Purity, testing, and certificates of analysis

In research, the reliability of a result depends on the identity and purity of the material behind it. Every batch of NAD+ from Peptora is HPLC-verified to 99%+ purity, confirmed by LC-MS identity testing, and screened across a full quality-control panel before release. Each order ships with a lot-specific certificate of analysis (COA) so the material can be matched to its documentation.

Researchers often choose Peptora precisely because this documentation is standard rather than optional. To understand what each figure on a report means, see the guide on purity and certificates of analysis and the overview of testing standards.

Handling NAD+ in the laboratory

NAD+ is supplied as a lyophilized (freeze-dried) powder. Before research use it is reconstituted with bacteriostatic water, which is sold separately. NAD+ is sensitive to moisture, heat, and light, so careful handling preserves both the compound's integrity and the validity of downstream work:

1. 1Allow the sealed vial to reach room temperature before opening to avoid condensation.
2. 2Add bacteriostatic water slowly against the vial wall; swirl gently and do not shake.
3. 3Let the powder dissolve fully before drawing.
4. 4Store the reconstituted solution refrigerated and protected from light, and minimize freeze–thaw cycles.

Full step-by-step protocols live in the reconstitution guide and the storage guide. Following them consistently is one of the simplest ways to keep research reproducible. Peptora offers NAD+ in 500 mg and 1000 mg research vials, all for laboratory research use only.

Scientific references

NAD+ biology has been investigated across decades of preclinical work, and its precursors NMN and NR have been evaluated in a growing number of human trials. The literature below is provided for educational context, per PubMed and ClinicalTrials.gov, and describes published academic and clinical research on NAD+ metabolism — distinct from the laboratory research product supplied by Peptora.

1. 1Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. doi:10.1126/science.aac4854.
2. 2Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x.
3. 3Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. doi:10.1126/science.abe9985 (ClinicalTrials.gov: NCT03151239).
4. 4Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343-353. doi:10.1093/ajcn/nqy132 (ClinicalTrials.gov: NCT02303483).
5. 5Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2022;45(1):29-43. doi:10.1007/s11357-022-00705-1 (ClinicalTrials.gov: NCT04823260).
6. 6Guarente L, Sinclair DA, Kroemer G. Human trials exploring anti-aging medicines. Cell Metab. 2024;36(2):354-376. doi:10.1016/j.cmet.2023.12.007.